Arcus Biosciences, Inc. (RCUS) Operating margin 2017–2025
Arcus Biosciences, Inc. (RCUS) operating margin by fiscal year — reported operating income divided by reported revenue.
-1169.7%FY2025 · since FY2017: -3782.1% → -1169.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1169.7% | -522.6 pp |
| FY2024 | -647.1% | +271.9 pp |
| FY2023 | -918.9% | -182.1 pp |
| FY2022 | -736.8% | -750.9 pp |
| FY2021 | 14.1% | +173.1 pp |
| FY2020 | -159.0% | +432.4 pp |
| FY2019 | -591.4% | +65.4 pp |
| FY2018 | -656.8% | +3125.3 pp |
| FY2017 | -3782.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice